Literature DB >> 33299308

Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting - Part II: In vitro and in vivo Kinetics Study.

Aya Ahmed Sebak1, Iman Emam Omar Gomaa2, Aliaa Nabil ElMeshad3, Mahmoud Hussien Farag1, Ulrike Breitinger4, Hans-Georg Breitinger4, Mahmoud Hashem AbdelKader5,6.   

Abstract

INTRODUCTION: Nanoparticles (NPs), upon introduction to the biological systems, become wrapped by serum and cellular proteins constituting the protein corona (PC). This PC contributes largely to the NPs' interaction with the biological systems and their subsequent functions. On the one hand, PC can decrease the efficiency of targeting by directing the NPs to the reticuloendothelial system (RES) or by masking the active targeting moieties and decreasing their ability to bind to their target receptors. On the other hand, some components of PC have offered hopes for achieving endogenous targeting.
METHODS: In this study, we aimed at the investigation of the role of the PC in determining the behavior of cRGDyk peptide-unconjugated and -conjugated NPs (uNPs and cNPs) exhibiting different physicochemical properties and their interaction with melanoma on in vitro and in vivo levels. Mathematical modeling has been utilized to understand the kinetics of the interaction of NPs with the tumor cells and different organs, respectively.
RESULTS: Endocytosis and exocytosis were reported to occur simultaneously for the utilized NPs. The balance was largely dependent on the NPs' physicochemical properties and the role of the PC. In addition, distinct proteins present in the PC (illustrated in the results of the PC analysis in part I) have also determined the patterns of the NPs' distribution in different organs and tissues of the vascular system, the RES system and the target tumot tissue. Vitronectin (VN) was found to mediate higher accumulation in integrin receptor-expressing melanoma cells, while complement 3 protein (C3) and clusterin (CLU), as an opsonin and dysopsonin, respectively, regulated the balance between the RES uptake and blood circulation. DISCUSSION: PC, if properly modulated by tuning NPs' physicochemical properties, can serve as a potential venue for optimum utilization of NPs in cancer therapy.
© 2020 Sebak et al.

Entities:  

Keywords:  Protein corona; biodistribution; endocytosis; endogenous targeting; exocytosis; melanoma; pharmacokinetics

Mesh:

Substances:

Year:  2020        PMID: 33299308      PMCID: PMC7721286          DOI: 10.2147/IJN.S273721

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  86 in total

1.  Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells.

Authors:  Sara Palchetti; Daniela Pozzi; Anna Laura Capriotti; Giorgia La Barbera; Riccardo Zenezini Chiozzi; Luca Digiacomo; Giovanna Peruzzi; Giulio Caracciolo; Aldo Laganà
Journal:  Colloids Surf B Biointerfaces       Date:  2017-02-28       Impact factor: 5.268

2.  Tunable rigidity of (polymeric core)-(lipid shell) nanoparticles for regulated cellular uptake.

Authors:  Jiashu Sun; Lu Zhang; Jiuling Wang; Qiang Feng; Dingbin Liu; Qifang Yin; Dongyan Xu; Yujie Wei; Baoquan Ding; Xinghua Shi; Xingyu Jiang
Journal:  Adv Mater       Date:  2014-12-22       Impact factor: 30.849

3.  Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics.

Authors:  Anna Salvati; Christoffer Aberg; Tiago dos Santos; Juan Varela; Paulo Pinto; Iseult Lynch; Kenneth A Dawson
Journal:  Nanomedicine       Date:  2011-03-29       Impact factor: 5.307

4.  Fate of cerium dioxide nanoparticles in endothelial cells: exocytosis.

Authors:  Claudia Strobel; Hartmut Oehring; Rudolf Herrmann; Martin Förster; Armin Reller; Ingrid Hilger
Journal:  J Nanopart Res       Date:  2015-05-05       Impact factor: 2.253

5.  The impact of receptor recycling on the exocytosis of αvβ3 integrin targeted gold nanoparticles.

Authors:  Yanan Cui; Xiaoning Song; Suxin Li; Bing He; Lan Yuan; Wenbing Dai; Hua Zhang; Xueqing Wang; Bin Yang; Qiang Zhang
Journal:  Oncotarget       Date:  2017-06-13

6.  Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines.

Authors:  Juan P Peñaloza; Valeria Márquez-Miranda; Mauricio Cabaña-Brunod; Rodrigo Reyes-Ramírez; Felipe M Llancalahuen; Cristian Vilos; Fernanda Maldonado-Biermann; Luis A Velásquez; Juan A Fuentes; Fernando D González-Nilo; Maité Rodríguez-Díaz; Carolina Otero
Journal:  J Nanobiotechnology       Date:  2017-01-03       Impact factor: 10.435

7.  Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.

Authors:  Pedram Rafiei; Azita Haddadi
Journal:  Int J Nanomedicine       Date:  2017-01-27

8.  Influence of chitosan coating on the oral bioavailability of gold nanoparticles in rats.

Authors:  Ahmed Alalaiwe; Paul Carpinone; Saad Alshahrani; Bader Alsulays; Mohammed Ansari; Mohammed Anwer; Sultan Alshehri; Abdullah Alshetaili
Journal:  Saudi Pharm J       Date:  2018-09-21       Impact factor: 4.330

Review 9.  Protein Adsorption: A Feasible Method for Nanoparticle Functionalization?

Authors:  Roberta Cagliani; Francesca Gatto; Giuseppe Bardi
Journal:  Materials (Basel)       Date:  2019-06-21       Impact factor: 3.623

10.  Vitronectin absorbed on nanoparticles mediate cell viability/proliferation and uptake by 3T3 Swiss albino mouse fibroblasts: in vitro study.

Authors:  F Rosso; G Marino; A Grimaldi; G Cafiero; E Chiellini; F Chiellini; M Barbarisi; A Barbarisi
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

View more
  1 in total

Review 1.  Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.

Authors:  Anna Salvati; Klaas Poelstra
Journal:  Pharmaceutics       Date:  2022-01-17       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.